Oct 22, 2015


The Caring for Carcinoid Foundation has offered a $600,000 award for the development of new cell lines that replicate the characteristics and genetics of carcinoid and pancreatic neuroendocrine (PNET) tumors.

This is the second open competition sponsored by the foundation—a $300,000 award was offered in 2014, and entries are currently under evaluation.

The $600,000 will be awarded in up to ten individual prizes: developers of the first new intestinal carcinoid and PNET cell lines will receive $100,000 each, and developers of the second, third, fourth, and fifth cell lines in each disease will receive $50,000 each. Developers are eligible to win a combination of these prizes, or all of them.

View details about the carcinoid and PNET cell line challenge. >

The need for well-validated and accepted carcinoid and PNET cell lines has significantly limited the development of new therapies for these deadly diseases. The Caring for Carcinoid Foundation’s goal with the challenges is to create a collection of cell lines that will be freely available to researchers around the world.

The winning cell lines will become part of the non-profit American Type Culture Collection (ATCC), the world’s largest cell line repository. ATCC will establish a new Neuroendocrine Tumor Cell Line collection in their catalog.

Also partnering in the challenge is the Rare Cancer Research Foundation. RCRF’s mission is to directly advance efforts to develop new and better therapies to treat rare cancers, the leading cause of cancer death in the U.S.

We encourage our current and future ALT customers to get involved in this important research challenge—register today on Innocentive.com.

Visit the American Type Culture Collection website. >